BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
ID: CBRND-BAA-22-01Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW6QK ACC-APGABERDEEN PROVING GROU, MD, 21010-5424, USA

PSC

NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH (AC12)
Timeline
    Description

    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.

    Point(s) of Contact
    Files
    Title
    Posted
    The Army Contracting Command at Aberdeen Proving Ground has issued a Broad Agency Announcement (BAA) for research and development efforts supporting the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). Proposals are solicited from eligible organizations, including educational institutions and private industry, focusing on advanced medical countermeasures and enabling technologies for CBRN threats, with awards potentially involving procurement contracts, grants, or other transaction agreements. The announcement provides comprehensive guidelines for proposal submission, evaluation criteria, and administrative details for applicants.
    Similar Opportunities
    CBRND Professional Services JPM P Task Order Draft
    Active
    Dept Of Defense
    The Department of Defense, specifically the Joint Program Executive Office for Chemical Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is seeking proposals for a Task Order Request (TOR W911QY-25-R-JP01) focused on Engineering, Testing, and Logistics Support Services. This procurement is a small-business set-aside aimed at enhancing CBRN capabilities for the U.S. Marine Corps and Special Operations Forces, emphasizing the development and sustainment of integrated defense solutions against chemical, biological, radiological, and nuclear threats. Interested contractors must comply with specific submission criteria and deadlines, with proposals evaluated based on past performance, technical capabilities, and cost. Questions regarding the solicitation should be directed to Claire Choi or Andrew Richard via email, with a deadline for inquiries set for December 23, 2024.
    JPEO-CBRND CWMD BOTAA-24-01
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEPT OF THE ARMY: The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking funding through Other Transaction Authority agreements (OTAs) for prototype and follow-on production projects within JPEO-CBRND mission areas of interest. The service being procured is the development of enabling technologies that speed up the advanced development process. This opportunity is open to all eligible sources, including educational institutions, nonprofit organizations, and private industry. Proposals are to be submitted in accordance with the provided guidelines. For more information, please refer to the JPEO-CBRND website.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), is soliciting proposals through a Broad Agency Announcement (BAA) for innovative solutions in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. The BAA invites participation from a wide range of eligible sources, including educational institutions, nonprofit organizations, and private industry, to develop technologies such as sensor systems, aerosol technologies, and decontamination methods. This initiative is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' effectiveness on the battlefield and in homeland defense. Interested parties can submit preproposals at any time, with contact points for inquiries being Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil and Lionel Love at lionel.d.love.civ@army.mil.
    DRAFT REQUEST FOR PROPOSAL CBRN IDIQ RECOMPETE
    Active
    General Services Administration
    The General Services Administration (GSA) is seeking proposals for a Multiple Award Indefinite Delivery, Indefinite Quantity (IDIQ) contract to support the Joint Program Executive Office (JPEO) for Chemical, Biological, Radiological, and Nuclear Defense (CBRND) with brand name commercial supplies. This procurement is exclusively reserved for small businesses, with an estimated ceiling value of $500 million over a five-and-a-half year period, focusing on essential CBRN defense tools such as personal protective equipment and detection devices. The initiative underscores the importance of enhancing military capabilities and ensuring compliance with federal acquisition practices, with proposals due by March XX, 2025. Interested contractors can direct inquiries to Abbey Gallivan at abbey.gallivan@gsa.gov or Jen Sutherland at jennifer.sutherland@gsa.gov for further clarification.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    Scientific Technical Administrative and Logistical Support Services Request for Proposal
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting proposals for Scientific Technical Administrative and Logistical Support Services. This procurement aims to provide essential support services that facilitate research and development in biotechnology, specifically excluding nanobiotechnology, as outlined under NAICS code 541714. The services are critical for advancing health-related research and healthcare services, ensuring the effective operation of various health initiatives. Interested small businesses are encouraged to reach out to the primary contact, James Cheng, at james.cheng1.civ@health.mil or 301-619-1012, or the secondary contact, Courtney Piar, at courtney.a.piar.civ@health.mil or 240-367-2228, for further details regarding the solicitation and any questions they may have.
    Hybridoma Development Studies and Antibody Production
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting proposals for a contract focused on hybridoma development studies and antibody production for the Division of Virology at the USAMRIID. The objective of this procurement is to secure severable, non-personal services that will support research in molecular virology, cell biology, immunology, and related fields. This work is critical for advancing understanding in viral virulence factors and strain diversity, which are essential for public health and military readiness. Interested small businesses are encouraged to reach out to Shelley Wallace at shelley.a.wallace2.civ@health.mil or 301-619-1352, or Emily OHara at emily.k.ohara.civ@health.mil or 301-619-9599 for further details regarding the solicitation.
    2025 CB Warfighter Engagements
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Threat Reduction Agency (DTRA), is seeking innovative technologies for the 2025 CB Warfighter Engagements aimed at enhancing capabilities in chemical, biological, and radiological (CBR) defense. This Request for Information (RFI) invites participation from industry and academia to develop technologies that will assist Warfighters in understanding, protecting against, and mitigating CBR threats, with a focus on three key events scheduled for April and June 2025. The initiative emphasizes the importance of rugged prototypes for hands-on evaluation and aims to foster collaboration between technology developers and military users to optimize defense readiness in contested environments. Interested parties should submit their proposals by December 30, 2024, and can direct inquiries to DTRA RD-CBW Submissions at dtra.belvoir.rd.mbx.rd-cbw-submissions@mail.mil.